SCHEMBL9744240

SCHEMBL9744240

CCOC(=O)C(/C=C(\C)CP(=O)(O)O)NC(C)C

nearest known ligand 0.60

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 1/20 0.60
CYP2C9 P11712 1/20 0.60
CYP2C19 P33261 1/20 0.60
GRIN2D O15399 1/20 0.43
GRIN3B O60391 1/20 0.43
GRIN1 Q05586 1/20 0.43
GRIN2A Q12879 1/20 0.43
GRIN2B Q13224 1/20 0.43
GRIN2C Q14957 1/20 0.43
GRIN3A Q8TCU5 1/20 0.43
BTN3A1 O00481 4/20 0.31
SMN1; SMN2 Q16637 1/20 0.30
HSD17B10 Q99714 1/20 0.30
ALDH1A1 P00352 1/20 0.30
HPGD P15428 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9840981 1.00 CYP2D6 (0.60) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL9744234 0.99 CYP2D6 (0.58) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
Hydrochloric Acid SCHEMBL9744246 0.99 CYP2D6 (0.58) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9744644 0.81 GRIN2D (0.56) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9744634 0.81 GRIN2D (0.56) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9744915 0.75 CYP2D6 (1.00) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL4575812 0.75 CYP2D6 (1.00) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9744929 0.75 CYP2D6 (1.00) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL4575805 0.75 CYP2D6 (1.00) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B
SCHEMBL9744133 0.74 CYP2D6 (0.50) CYP2D6CYP2C9CYP2C19GRIN2DGRIN3B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-5175344-A Anticonvulsants, anxiolytic agents CIBA-GEIGY CORPORATION (US) 1992-12-29 US disclosed
US-5051413-A For treatment of ischemia, antispasmodic agents, anticonvulsants and anxiety or manic conditions CIBA-GEIGY CORPORATION (US) 1991-09-24 US disclosed
EP-0302826-A2 Process for the preparation of unsaturated amino acid compounds CIBA-GEIGY AG (CH) 1989-02-08 EP disclosed